{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions ds"],"components":["Active, inactive sd"],"effective_time":"20190517","id":"891a69a7-e005-c8c5-e053-2995a90ab49e","instructions_for_use":["Directions for use aa"],"openfda":{},"package_label_principal_display_panel":["NDC 72934- 1047-2 CIMETIDINE USP 5% / IBUPROFEN USP 2% / SALICYLIC ACID USP 17%. Gel 30gm. sf"],"set_id":"891a69a7-e004-c8c5-e053-2995a90ab49e","spl_product_data_elements":["CIMETIDINE 5% / IBUPROFEN 2% / SALICYLIC ACID 17% CIMETIDINE 5% / IBUPROFEN 2% / SALICYLIC ACID 17% IBUPROFEN IBUPROFEN CIMETIDINE CIMETIDINE SALICYLIC ACID SALICYLIC ACID"],"version":"1"}